Emerging Biopharma

Dedicated to your success

Win with a team dedicated to advancing your innovation, backed by the power of IQVIA. Maximize your asset’s probability of success in a complex, competitive environment with comprehensive solutions that intelligently connect best-in-class insights, technology, and expertise.
Start small, dream big, succeed now

Develop and execute a winning asset launch strategy

For emerging biopharma and biotech companies to excel in today’s challenging environment, it’s critical to leverage a deep understanding of the patient profile and market dynamics throughout the journey from clinical to commercial. IQVIA Asset Maximizer is a comprehensive suite of solutions, delivered by experts dedicated to you, to help your breakthroughs get to patients, faster.

Asset success starts early for pharmaceutical companies with a need to ensure clinical trial design considers endpoints that demonstrate value to regulators, payers, prescribers, and the patient. Communicating that value requires an adaptable, omnichannel approach to activate and engage all stakeholders at launch and throughout the product lifecycle. Work with IQVIA, the global leader in clinical development, Real World Evidence, and the commercialization of new treatments to deliver a winning asset at launch and beyond.

Webinar

The 2024 State of the Payer: Dawn of a New Era

Discover the key trends that will impact the U.S. landscape in 2024. We delve into the effects of the Inflation Reduction Act, which is reshaping the industry and advancing obesity treatment. Additionally, we analyze how current dynamics will influence strategic decisions for the next decade.

Connecting people, intelligence, and innovation

IQVIA creates the connections for clinical and commercial customers to bring therapies to market and to the patients who need them. 

Contact Us